Triple Antiretroviral Therapy Improves Pregnancy Outcomes

NEW YORK (Reuters Health) — Besides preventing HIV-1 mother-to-child transmission (PMTCT), triple antiretroviral therapy during pregnancy improves pregnancy outcomes, according to findings published in the June 6th online AIDS.

For more information, please visit:

Value Independent Journalism?
We Need You Now More Than Ever

We need your help now, and we need it more than ever before. The free press, a keystone of democracy, is under attack by the incoming president of the United States. And we are asking you to support our work by making a donation. Now. Your contribution is 100% tax deductible.


Thank you for supporting our work!